Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B
Clinical trial NCT02482272 · UNKNOWN
Trial details
- NCT number
- NCT02482272
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-01-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.